# EQUITY FLOW LINE v2.1 — TARGETED REVIEW: FUNDING MECHANICS & UTILIZATION RISK Reviewer: senior credit + venture/PE lens (adversarial). Date: 2026-08-01. Scope: single-question review per mandate — attack concept Section 4's six open questions using line_funding_model.py's own formula plus an independent rebuild. Materials: concepts/EQUITY-FLOW-LINE-V21-CONCEPT.md, concepts/line_funding_model.py, concepts/LINE-FUNDING-RESULTS.txt, concepts/review-investor.md (HomeDraw v0.1, the tenure-product predecessor to this Line), reviews/investor.md (Equity Flow Stage 1). All figures below independently computed in Python (script preserved at session scratchpad: line_review_model.py); shown inline. Framing per mandate: assume the product has already failed; explain why. Note up front: this is a genuine, well-specified improvement over the tenure product's funding story in one respect — the concept explicitly separates a 100%-prefunded, contractually-unpausable SCHEDULED core from a reserve-based, best-efforts ON-DEMAND shell, and it built a real formula (reserve_drag) instead of asserting a number. That discipline is why this review can attack it with arithmetic rather than adjectives. The arithmetic does not survive. --- ## 1. WRONG-WAY UTILIZATION (concept Q1) **Finding L1 — rho=10% is exhausted by ordinary stress, not tail stress.** The reserve-exhaustion condition, using the model's own reserve mechanic: a shell reserve of size rho x undrawn fails once cumulative stress-period draws (m x normal-draw-rate x response-lag-months) exceed rho. L (months to arrange replacement capacity) | m to exhaust rho=10% | rho=25% 1 | 6.67x | 16.67x 2 | 3.33x | 8.33x 3 | 2.22x | 5.56x 6 | 1.11x | 2.78x Baseline assumption: normal on-demand draw flow = 1.5%/month of undrawn shell capacity [assumption — needs real underwriting data; flagged as the #1 validation need in the verdict]. At a 3-month capacity-replacement lag — itself an OPTIMISTIC assumption; see L2 — rho=10% fails at just a 2.2x draw-spike. At a 6-month lag, essentially ANY sustained elevated draw activity (1.1x) exhausts it. These are not tail multiples: 2020 corporate-revolver drawdowns ran 3-6x normal pace in weeks; 2008-09 saw ~20%+ of outstanding HELOC accounts frozen or cut by originating banks, with documented defensive/anticipatory draws by borrowers who sensed a freeze coming — a run dynamic, not a smooth demand curve. Severity: **CRITICAL**. **Finding L2 — the honest 1-in-20 stress requires rho approximately equal to the "hard-committed" case, defeating the point of the shell design.** Using a defensible 1-in-20 stress (m=5x sustained for L=3-6 months, grounded in the 2020 revolver and 2008 HELOC-freeze precedents above): rho_needed = 5.0 x 1.5% x 3 = 22.5% to 5.0 x 1.5% x 6 = 45.0%. The concept's own grid treats rho=25% as the "hard-committed line" reserve level and rho=10% as the cheaper "core+shell" compromise the whole Phase-2 pricing story depends on. An honest tail reserve lands AT OR ABOVE the "hard-committed" number. The "best-efforts above a guaranteed floor" framing is a documentation nicety, not an economic difference, once sized to the tail — "best efforts" does not fund a draw if the warehouse is gone, and 2007-08 shows that for a novel, unrated, non-bank second-lien asset class, warehouse capacity does not reliably return on any predictable timeline (see L3). Severity: **CRITICAL** — this alone moves the required rate materially (below). **Finding L3 — the correlation is the whole problem, and it runs one direction.** The scenario the concept must underwrite is not "draws spike" in isolation; it is draws spiking EXACTLY AS warehouse/equity capacity tightens or disappears — the same macro shock hits both sides simultaneously (2008: subprime/Alt-A non-bank originators lost warehouse lines within days-to-weeks on margin calls, and many lines never returned; 2020: JPMorgan and Wells Fargo suspended new HELOC originations for months). A response-lag assumption of 3-6 months (used above) is therefore itself charitable — the honest tail case is "capacity does not return in-period at all," which pushes required rho toward 50%+ or toward an explicit statement that the 5-business-day promise is not honorable in a systemic downturn and must be re-papered as conditional. Severity: **CRITICAL**. **Rate impact (model's own reserve_drag formula, rho x (1-u)/u x (hurdle-cash_y)):** u | rho=10% (concept) | rho=27.5% (central honest) | rho=35% (severe) 30% | 1.28% | 3.53% | 4.49% 40% | 0.83% | 2.27% | 2.89% 50% | 0.55% | 1.51% | 1.93% 60% | 0.37% | 1.01% | 1.28% 70% | 0.24% | 0.65% | 0.83% At realistic utilization (u=50%), honest reserve sizing alone adds **+96bps to +138bps** to the required consumer rate versus the concept's rho=10% design point. --- ## 2. ADVERSE SELECTION AT THE DRAW (concept Q2) **Finding L4 — EL=50bps blended is not defensible for the on-demand slice.** No income qualification on an on-demand draw means the marginal draw is placed by the household best informed about its own imminent distress — precisely the cohort about to miss a senior-mortgage payment. Recovery on a junior, non-recourse position behind a defaulting senior is near-total loss (per the predecessor HomeDraw review's D1 finding: junior surplus recovery after a senior foreclosure is 0-50%, mode near 0; here the collateral is unseasoned and smaller, so LGD is worse, not better). PD (cumulative 5-yr senior-default probability, on-demand-draw cohort): 8-12% [SPECULATIVE point estimate — no vintage data exists for this exact box; directionally anchored to well-documented GFC-era second-lien/HELOC loss experience, where no-income-verification junior seconds behind a since-defaulted senior were substantially wiped out] LGD (junior, non-recourse, behind a defaulted senior): 90% Cumulative EL: 7.2% - 10.8% -> annualized over a 6-yr average on-demand outstanding life: **120-180bps/yr**, point estimate 150bps/yr. Blended against a lower-risk scheduled/autopay slice (60bps/yr, consistent with the parent tenure product's D1 finding of 40-60bps/yr): on-demand $ share of drawn book | blended EL 30% | 0.87% 40% | 0.96% 50% | 1.05% Central corrected EL: **~0.95-1.0%**, i.e., **+45 to +55bps** versus the model's flat 50bps. Severity: **MAJOR** (smaller in isolation than L1/L2, but it does not offset — it stacks). **Finding L5 — the "confirmed with a plain-dollar cost preview before funding" UX feature is a disclosure fix, not a selection fix.** It does nothing to change who chooses to draw; it only makes the choice better-informed for the distressed borrower who is drawing anyway. Severity: MINOR (as a mitigant to L4, effectively zero). --- ## 3. FUNDING STRUCTURE REALITY (concept Q3) — the single largest correction **Finding L6 — the "revolving PIK master-trust" is a category error, and it is the biggest number in this review.** A credit-card master trust works because current cash finance charges (18-25% coupon collections) service the trust's cash-pay bonds monthly; a revolving structure with NO current cash yield has nothing to pay bondholders with during the revolving period. This Line is fully deferred-interest — zero cash generated until sale/move-out/death, 8-25 years out on the parent tenure product's own WAL estimate. A rated, cash-pay ABS coupon (the model's assumed 6.5% at 85% advance) cannot be serviced by a non-cash-pay collateral pool without either (a) a fully cash-funded interest reserve, which erodes the advance-rate economics back toward equity cost, or (b) the bonds themselves being PIK/zero-coupon, which do not clear at 6.5% — the nearest true PIK/non-recourse comp (proprietary reverse-mortgage RMBS) prices double-digit all-in and is anchored to a mortality curve this under-62, behavior-driven collateral does not have. Credit-card ABS and pre-2008 HELOC ABS are both worse comps in opposite directions: credit cards work only because of the current cash yield this product deliberately forgoes; pre-08 stand-alone/piggyback second-lien HELOC ABS is the graveyard comp (severe crisis-era losses, junior tranches near-wiped, market did not meaningfully reopen for a decade-plus) — and even that collateral was cash-pay interest-only, a materially better cash profile than this fully-deferred design. **The pre-08 HELOC ABS graveyard is the better precedent, and this product is structurally worse than what died there.** Corrected post-takeout blended funding cost, using the one funding idea this review's predecessor found credible (whole-loan forward-flow sale to a life insurer/balance-sheet buyer, not a rated cash-pay ABS shelf), at a realistic insurer all-in yield for unseasoned, non-cash-pay junior paper (8.75%, informed by the predecessor review's finding that insurer bids on this asset class start north of 10% until performance exists — 8.75% is already a scale/seasoning discount to that, not a day-one number), blended 70/30 with equity at 12%: F_PRE (model, unchanged) = 9.30% F_POST (model's ABS assumption) = 7.33% F_POST_corrected (insurer forward-flow) = **9.72%** Realistic post-takeout funding is barely below pre-takeout funding. **The concept's central "Phase gating" thesis — wait for the rated takeout, and the Line becomes affordable at ~9.75% — does not deliver the unlock it promises,** because the unlock (7.33%) does not exist for this collateral type; the achievable number (9.72%) is 239bps higher than modeled. This single correction is larger than the L1-L2 reserve correction and the L4 EL correction combined. Severity: **CRITICAL**. **Finding L7 — no warehouse lends against undrawn commitments (the model gets this right implicitly, but the concept's narrative doesn't grapple with what it costs).** Standard revolving-consumer-credit warehouse practice extends credit only against drawn, funded receivables; undrawn approved capacity carries zero advance value. The model's reserve_drag formula correctly prices the undrawn shell at pure equity cost (12%) — but the concept text (Section 2, "capacity reserves attach at first draw... costs the customer nothing, forever") reads as though undrawn capacity is free to the platform. It is not: every approved, undrawn line that is ever drawn even partially requires its reserve slice funded at equity cost from day one of the shell's existence, and the model already shows (L1/L2) that shell must be sized far larger than 10%. Severity: MAJOR (narrative/expectations gap; the cost is real, just not where the concept's marketing language implies it lives). --- ## 4. DORMANCY / CAC (concept Q4) **Finding L8 — the delivered model does not price dormancy at all; this is the concept's own open question, unmodeled.** required_rate() in line_funding_model.py takes a fixed orig_cost parameter (default $1,500) and divides by drawn-dollar-years; it never varies by activation rate. The "SMALL-ACCOUNT BREAKEVEN" table in LINE-FUNDING-RESULTS.txt (testing $5,300/$2,500/$1,500/$800) silently assumes every dollar of origination cost attaches to a funded, revenue-bearing account — i.e., activation = 100%. A product whose entire premise is "approval is free, capacity attaches only at first draw" will not see 100% activation; the whole point of a no-obligation approval is that many approved households never draw. Rebuild with marketing/approval cost separated from at-draw origination cost (cost per APPROVED line ~$400 for credit pull/AVM/light underwriting, illustrative — not in the concept; full origination cost at first draw held at the concept's own $500 target): activation rate | CAC per FUNDED account (mktg only) | total cost/funded 20% | $2,000 | $2,500 40% | $1,000 | $1,500 60% | $667 | $1,167 Fed through the concept's own breakeven mechanic (spread ~132bps post-takeout): 20% activation: needs 189,394 drawn-$-years (~$37,879 avg drawn for 5yr) 40% activation: needs 113,636 drawn-$-years (~$22,727 avg drawn for 5yr) 60% activation: needs 88,384 drawn-$-years (~$17,677 avg drawn for 5yr) At 40% activation the total cost/funded account ($1,500) happens to match the model's unexamined default — coincidence, not validation. At a plausible lower-bound activation rate for a free, no-obligation approval product (20% — consistent with typical unused/dormant pre-approved-credit behavior), the true cost per funded account is 67% higher than the model's assumption, and the required average drawn balance to break even ($37,879 held 5 years) is well above what the concept's own flagship archetypes show for the SMALL-draw use case (the $12K unemployment bridge). **Small-draw, low-activation accounts — exactly the "costs nothing, forever" marketing promise's core audience — are structurally underwater**, and the deficit is cross-subsidized either by (a) large-balance accounts, which per Section 2's adverse-selection finding (L4) skew toward the pre-distress cohort, or (b) undisclosed platform equity burn. Severity: **MAJOR** (compounds directly with L4: the accounts large enough to be profitable are the accounts most likely to default). --- ## 5. PHASE-TRANSITION CANNIBALIZATION (concept Q5) **Finding L9 — the architecture requires Phase 1 to fund Phase 2's takeout while Phase 2's existence undermines Phase 1's volume; this is a closed loop, not a sequencing footnote.** The concept states the tenure product (Phase 1) must reach u≈90% "by construction" and generate the collateral mass for a rated takeout that then unlocks the Line (Phase 2) at ~9.75%. But any prospective customer who becomes aware a more flexible, cheaper-at-scale product is coming has a dominant rational strategy: wait. This is the Osborne effect (a well-known pattern in product marketing — publicly announcing a superior successor collapses demand for the current product before the successor ships) and it is structurally worse here than the typical case, because the two products serve overlapping — not merely adjacent — need states: the concept's own Section 1 frames the Line as a strict superset of the tenure product ("the tenure schedule reframed as an autopay feature ON the line"), so there is no genuine positioning gap to hide behind. A prospect told "the committed schedule is one mode of a broader line we're building" has no reason to take the narrower, currently-available product over waiting. Quantified exposure: the predecessor HomeDraw review already found realistic Phase-1 origination pace to be "low thousands of deals/yr from a cold start" (M3) and the collateral-mass requirement for a securitizable pool to be 4,000-6,000 loans / $250-300M (S2), itself a 3-5 year build even at full committed volume. Any cannibalization discount on Phase-1 volume (a 20-40% deferral rate among prospects who become aware of the roadmap is a plausible, unvalidated range) pushes the collateral-mass date out proportionally, which pushes the rated-takeout date out, which — per Finding L6 — does not even deliver the promised funding-cost unlock when it arrives. The dependency chain (Phase 1 volume -> collateral mass -> rated takeout -> Phase 2 pricing) is undermined at its first link by the mere existence of the plan for its last link. Severity: **MAJOR**, escalating to CRITICAL if the roadmap is disclosed pre-launch (investor decks, press, or sales-rep knowledge all count as disclosure; the concept document itself, once shared outside a tightly controlled review process, is a leak vector). Mitigant: do not publicly sequence Phase 1/Phase 2; market the committed schedule on its own genuine merits (true product-market difference: the concept's own framing distinguishes "wants committed monthly income" from "wants flexible self-directed draws" as different buyer intents) — but this mitigant is in tension with the standard practice of pitching a full roadmap to investors and press, which this review has no basis to assume will be suppressed. --- ## 6. VERDICT: does the corrected rate stay <=10.5%? **No.** Combining Findings L1/L2 (honest rho), L4 (corrected EL), L6 (realistic funding), and L8 (dormancy-adjusted origination cost) through the model's own required_rate mechanic: SCENARIO | RATE MODEL ORIGINAL (rho=10%, u=50%, EL=0.50%, funding=7.33%) | 9.73% BEST-PLAUSIBLE (rho=20%, u=70%, EL=0.80%, act=60%) | 12.24% CENTRAL (rho=27.5%, u=50%, EL=0.96%, act=40%) | 13.55% SEVERE (rho=35%, u=40%, EL=1.05%, act=20%) | 15.28% Decomposition of the central-case gap (13.55% vs model's 9.73%, +382bps): funding-structure correction +239bps (largest single lever), reserve/rho correction +96bps, EL correction +46bps, origination/dormancy ~flat at the 40%-activation midpoint (material only at the low-activation tail). Even the most generous internally-consistent combination this review can construct (high utilization, moderate reserve, moderate activation) still prices at 12.24% — 174bps above the HELOC-competitiveness ceiling identified in the v2 reviews. **There is no combination of honest corrections that clears 10.5%.** The concept's headline 9.75%/9.45% figures are reachable only by holding all three corrections at their most optimistic settings simultaneously (rho=10%, EL=50bps, and a cash-pay ABS market that this review argues does not exist for PIK second-lien collateral) — which is exactly the combination an adversarial reviewer should not grant. **Interaction with the tenure-product (HomeDraw v0.1) predecessor verdict:** that review found the sustaining note rate for the deferred-interest tenure product to be 11-13% against the same ~10-10.5% consumer ceiling, and issued FIX-BEFORE-LAUNCH conditioned on (1) resolving the Reg Z reverse-mortgage fork, (2) securing an anchor insurer takeout before scale, and (3) demonstrating demand at the sustaining rate. This Line generalization inherits all three conditions unresolved (the Reg Z classification target is asserted, not confirmed, per concept Section 1; the anchor-takeout condition is the same insurer thesis this review now prices at 9.72-9.75%, not the concept's 6.5%; demand-at-sustaining-rate is untested) and adds a fourth, harder condition of its own: a funding structure that plausibly exists at all for revolving, fully-PIK, non-recourse consumer collateral. No such structure has been demonstrated in the market at any scale (Finding L6). ### THE THREE THINGS THAT MUST BE TRUE (in addition to the predecessor review's three conditions, which still gate this product), each in writing before a dollar of Phase-2 origination: 1. **A REAL FUNDING STRUCTURE, NAMED AND PRICED, NOT ASSUMED.** Written terms (indicative or committed) from an actual balance-sheet buyer for the PIK/non-recourse/revolving asset class — whole-loan forward-flow to a life insurer is the only candidate this review or its predecessor finds credible — at an all-in cost that, run through the model above, keeps the consumer rate at or below 10.5%. Absent that, "Phase 2 unlocked by takeout" is a narrative, not a plan. 2. **RESERVE SIZING TO AN HONEST STRESS TEST, NOT A DESIGN-CHOICE LABEL.** rho must be set by a modeled draw-run scenario (2008/2020-calibrated, at minimum m=5x for L=3-6 months) rather than chosen for its effect on the headline rate. If the honest number is ~25-35%, say so and reprice, rather than defaulting to the 10% cell of the grid because it is the one that produces an acceptable answer. 3. **ACTIVATION-RATE VALIDATION BEFORE THE "COSTS NOTHING, FOREVER" PROMISE SHIPS.** A real cohort test of approval-to-first-draw conversion (target: a funnel pilot, not a benchmark assumption) — because at any activation rate below ~40%, the small-draw, high-altruism use cases this product is proudest of (the $12K unemployment bridge) are the ones priced out first. **VERDICT for the LINE variant specifically: KILL as specified; FIX-BEFORE-LAUNCH only if condition 1 (a real funding structure) is resolved in writing before any Phase-2 marketing commitment is made** — and even then, the corrected central-case rate (13.55%, best-plausible-case 12.24%) is materially above the 10.5% ceiling, meaning "fix" here means a different capital structure and a different (lower, non-ABS-dependent) cost target, not a parameter tweak to the existing model. **Corrected parameter set this review would underwrite (central case):** rho = 27.5% (shell reserve, honest 1-in-20 draw-run stress), EL = 0.95-1.00% blended (assuming ~40% of drawn dollars are on-demand), funding = 9.7% (insurer whole-loan forward-flow, not cash-pay ABS), u = 50%, activation = 40% (unvalidated — see below), **required consumer rate ~13.5%** — against an 8-8.5% HELOC alternative and the review's own 10.5% competitiveness ceiling, this does not clear as a consumer-sellable product at scale under the LINE's flexible/on-demand design; it clears only as a narrower, scheduled-disbursement-only product (i.e., functionally the Phase-1 tenure product this Line was built to extend beyond). **The single assumption most needing real-world validation:** activation rate (approval-to-first-draw conversion) is entirely unmodeled in the delivered script and entirely unvalidated in the concept — it is simultaneously the lever with the widest plausible range (20-60%+, a 3x swing) and the lever that determines whether the product's proudest marketing claim ("approval costs the customer nothing, forever") is a true statement about the PLATFORM's economics or merely a true statement about the CONSUMER's bill. Everything else in this review (reserve sizing, EL, funding structure) can be bounded from public precedent; activation cannot, because no comparable product (free approval, capacity-at-first-draw, revolving, non-recourse home-secured line) has been marketed at scale to know what the real number is. **Legal/tax claim tags used in this review:** the Reg Z reverse-mortgage classification target inherited from concept Section 1 is unchanged from and still gated by the predecessor review's O1 finding [LIKELY INTERPRETATION on classification; LIKELY on the ATR consequence — unresolved, carried forward, not re-litigated in this funding-focused review]. No new legal or tax claims are introduced in this document; all findings above are financial-modeling and market-structure claims (funding-cost comps, historical draw-behavior precedent, and CAC/activation economics), none of which carry a legal-status tag under the house taxonomy. --- end of review ---